Skipping hormone therapy may be okay for older breast cancer patients

According to a new study, breast cancer patients over age 60 with small, early-stage tumors can skip hormone therapy without worrying about an increased risk of death.

Kidney-cancer drug prevents breast cancer from worsening: study

A “game-changing” study by the Swiss drug maker Novartis has shown that its kidney-cancer drug Afinitor also works to slow breast cancer’s progression.

Breast preservation possible for lobular breast cancer patients

About half of women with lobular breast cancer may be able to save their affected breast by undergoing chemotherapy prior to breast surgery, an Austrian study has found.

Elderly breast cancer patients risk heart problems with Herceptin

Older women with a history of heart disease or diabetes and who also take Herceptin are at increased risk of developing additional heart problems, according to a recent study.

Cancer vaccine approved by FDA for human testing

News brief: Promising new vaccine to help prevent breast and ovarian cancers in women now approved for human testing.

New therapy a possible alternative for women resistant to Herceptin

For women resistant to Herceptin, there is a new possible alternative called Affitoxin.

Fertility still possible for young patients enduring chemotherapy

There is a new drug called triptorelin that suppresses ovarian function and could help breast cancer patients preserve their fertility at a lower cost than cryopreservation.